Gut Microbiota-Derived Tryptophan Metabolites Modulate Inflammatory Response in Hepatocytes and Macrophages

SUMMARY The gut microbiota plays a significant role in the progression of fatty liver disease; however, the mediators and their mechanisms remain to be elucidated. Comparing metabolite profile differences between germ-free and conventionally raised mice against differences between mice fed a low- and high-fat diet (HFD), we identified tryptamine and indole-3-acetate (I3A) as metabolites that depend on the microbiota and are depleted under a HFD. Both metabolites reduced fatty-acid- and LPS-stimulated production of pro-inflammatory cytokines in macrophages and inhibited the migration of cells toward a chemokine, with I3A exhibiting greater potency. In hepatocytes, I3A attenuated inflammatory responses under lipid loading and reduced the expression of fatty acid synthase and sterol regulatory element-binding protein-1c. These effects were abrogated in the presence of an aryl-hydrocarbon receptor (AhR) antagonist, indicating that the effects are AhR dependent. Our results suggest that gut microbiota could influence inflammatory responses in the liver through metabolites engaging host receptors.

[1]  K. Birkeland,et al.  Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2. , 2006, Journal of hepatology.

[2]  Kyongbum Lee,et al.  Microbiome-Derived Tryptophan Metabolites and Their Aryl Hydrocarbon Receptor-Dependent Agonist and Antagonist Activities , 2014, Molecular Pharmacology.

[3]  E. Murphy,et al.  Influence of high-fat diet on gut microbiota: a driving force for chronic disease risk , 2015, Current opinion in clinical nutrition and metabolic care.

[4]  Rohit Loomba,et al.  The global NAFLD epidemic , 2013, Nature Reviews Gastroenterology &Hepatology.

[5]  M. Eslam,et al.  Genetics and epigenetics of NAFLD and NASH: Clinical impact. , 2018, Journal of hepatology.

[6]  Yi-horng Lee,et al.  The role of bile acids in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. , 2017, Molecular aspects of medicine.

[7]  Sabine Borwege,et al.  Nutrient Modification of the Innate Immune Response: A Novel Mechanism by Which Saturated Fatty Acids Greatly Amplify Monocyte Inflammation , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[8]  S. Rabot,et al.  Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice , 2012, Gut.

[9]  Ying Zhang,et al.  HMDB: the Human Metabolome Database , 2007, Nucleic Acids Res..

[10]  P. Newsome,et al.  Pathogenesis of non-alcoholic fatty liver disease , 2009, QJM : monthly journal of the Association of Physicians.

[11]  Matteo Ricchi,et al.  Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes , 2009, Journal of gastroenterology and hepatology.

[12]  Matthias Müller-Hannemann,et al.  In silico fragmentation for computer assisted identification of metabolite mass spectra , 2010, BMC Bioinformatics.

[13]  H. Gong,et al.  Effects of Excess Energy Intake on Glucose and Lipid Metabolism in C57BL/6 Mice , 2016, PloS one.

[14]  C. Day.  Non-alcoholic fatty liver disease: a massive problem. , 2011, Clinical medicine.

[15]  B. Eksteen,et al.  Murine models provide insight to the development of non-alcoholic fatty liver disease , 2015, Nutrition Research Reviews.

[16]  Andrew H. Van Benschoten,et al.  Discovery and characterization of gut microbiota decarboxylases that can produce the neurotransmitter tryptamine. , 2014, Cell host & microbe.

[17]  Brian J. Bennett,et al.  Expanding role of gut microbiota in lipid metabolism , 2016, Current opinion in lipidology.

[18]  Kyongbum Lee,et al.  Monoethylhexyl Phthalate Elicits an Inflammatory Response in Adipocytes Characterized by Alterations in Lipid and Cytokine Pathways , 2016, Environmental health perspectives.

[19]  S. Shimba,et al.  Aryl Hydrocarbon Receptor Plays Protective Roles against High Fat Diet (HFD)-induced Hepatic Steatosis and the Subsequent Lipotoxicity via Direct Transcriptional Regulation of Socs3 Gene Expression* , 2016, The Journal of Biological Chemistry.

[20]  H. Yoshimatsu,et al.  TNF-α Induces Hepatic Steatosis in Mice by Enhancing Gene Expression of Sterol Regulatory Element Binding Protein-1c (SREBP-1c) , 2007, Experimental biology and medicine.

[21]  David S. Wishart,et al.  CFM-ID: a web server for annotation, spectrum prediction and metabolite identification from tandem mass spectra , 2014, Nucleic Acids Res..

[22]  S. Chirtel,et al.  Effects of 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) on de novo fatty acid and cholesterol synthesis in the rat , 1988, Lipids.

[23]  A. Jayaraman,et al.  The bacterial signal indole increases epithelial-cell tight-junction resistance and attenuates indicators of inflammation , 2009, Proceedings of the National Academy of Sciences.

[24]  Min Jae Lee,et al.  A novel role for the dioxin receptor in fatty acid metabolism and hepatic steatosis. , 2010, Gastroenterology.

[25]  Denis Gris,et al.  Fatty acid–induced NLRP3-ASC inflammasome activation interferes with insulin signaling , 2011, Nature Immunology.

[26]  J. Preiß,et al.  Lipid metabolism and neuropsychological follow-up study of workers exposed to 2,3,7,8- tetrachlordibenzo-p-dioxin , 2002, International archives of occupational and environmental health.

[27]  Dong-Hyun Kim,et al.  High Fat Diet-Induced Gut Microbiota Exacerbates Inflammation and Obesity in Mice via the TLR4 Signaling Pathway , 2012, PloS one.

[28]  V. Dziedziejko,et al.  IL-1 and TNF-α regulation of aryl hydrocarbon receptor (AhR) expression in HSY human salivary cells. , 2014, Archives of oral biology.

[29]  William H. Bisson,et al.  Adaptation of the human aryl hydrocarbon receptor to sense microbiota-derived indoles , 2015, Scientific Reports.

[30]  J. Solís-Herruzo,et al.  In vitro treatment of HepG2 cells with saturated fatty acids reproduces mitochondrial dysfunction found in nonalcoholic steatohepatitis , 2014, Disease Models & Mechanisms.

[31]  Lorenza Putignani,et al.  Gut Microbiota Profiling: Metabolomics Based Approach to Unravel Compounds Affecting Human Health , 2016, Front. Microbiol..

[32]  Maria Pia Conte,et al.  Dysbiotic Events in Gut Microbiota: Impact on Human Health , 2014, Nutrients.

[33]  G. Gores,et al.  Free Fatty Acids Induce JNK-dependent Hepatocyte Lipoapoptosis* , 2006, Journal of Biological Chemistry.

[34]  L. Weber,et al.  Tissue-specific alterations of de novo fatty acid synthesis in 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-treated rats , 2004, Archives of Toxicology.

[35]  T. Luedde,et al.  Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury , 2011, Gut.

[36]  Kyongbum Lee,et al.  Prediction and quantification of bioactive microbiota metabolites in the mouse gut , 2014, Nature Communications.

[37]  R. Abagyan,et al.  METLIN: A Metabolite Mass Spectral Database , 2005, Therapeutic drug monitoring.

[38]  W. R. Wikoff,et al.  Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites , 2009, Proceedings of the National Academy of Sciences.

[39]  Frank Tacke,et al.  Macrophage heterogeneity in liver injury and fibrosis. , 2014, Journal of hepatology.

[40]  G. La Torre,et al.  Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease , 2009, Hepatology.

[41]  A. El-Kadi,et al.  Down-regulation of aryl hydrocarbon receptor-regulated genes by tumor necrosis factor-alpha and lipopolysaccharide in murine hepatoma Hepa 1c1c7 cells. , 2005, Journal of pharmaceutical sciences.

[42]  P. Bedossa,et al.  A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer , 2016, Journal of hepatology.

[43]  D. Ory,et al.  Palmitate and Lipopolysaccharide Trigger Synergistic Ceramide Production in Primary Macrophages* , 2012, The Journal of Biological Chemistry.

[44]  E. Tsochatzis,et al.  The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). , 2016, Metabolism: clinical and experimental.

[45]  J. Kirwan,et al.  Role of ceramides in nonalcoholic fatty liver disease , 2012, Trends in Endocrinology & Metabolism.

[46]  J. Flier,et al.  TLR4 links innate immunity and fatty acid-induced insulin resistance. , 2006, The Journal of clinical investigation.

[47]  M. Duvnjak,et al.  Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease. , 2014, World journal of gastroenterology.

[48]  G. Perdew,et al.  Role of the Ah receptor in homeostatic control of fatty acid synthesis in the liver. , 2012, Toxicological sciences : an official journal of the Society of Toxicology.

[49]  H. Cortez‐Pinto,et al.  Bile acid levels are increased in the liver of patients with steatohepatitis , 2008, European journal of gastroenterology & hepatology.

[50]  Bruce D Hammock,et al.  Development of a green fluorescent protein-based cell bioassay for the rapid and inexpensive detection and characterization of ah receptor agonists. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[51]  Chengfu Xu,et al.  Association between serum free fatty acid levels and nonalcoholic fatty liver disease: a cross-sectional study , 2014, Scientific Reports.

[52]  Bin Zhao,et al.  CH223191 is a ligand-selective antagonist of the Ah (Dioxin) receptor. , 2010, Toxicological sciences : an official journal of the Society of Toxicology.

[53]  Lixin Zhu,et al.  Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: A connection between endogenous alcohol and NASH , 2013, Hepatology.

[54]  S. Safe,et al.  Investigation of macrophage polarization using bone marrow derived macrophages. , 2013, Journal of visualized experiments : JoVE.